Use of chewing gum containing 15% of xylitol and reduction in mutans streptococci salivary levels
AUTOR(ES)
Fraga, Cláudia Perez Trindade, Mayer, Márcia Pinto Alves, Rodrigues, Célia Regina Martins Delgado
FONTE
Brazilian Oral Research
DATA DE PUBLICAÇÃO
2010-06
RESUMO
Frequent use of Xylitol may decrease the S. mutans levels. However, very little is known about whether this effect on the levels of cariogenic bacteria is maintained after the interruption of short-term usage of xylitol. This study aimed at evaluating changes in mutans streptococci (MS) salivary levels after using a chewing gum containing xylitol. Twelve volunteers harboring > 10(5) CFU MS/ml saliva levels were asked to chew Happydent-xylit® for 5 minutes, 5 X/day, for 30 days. Saliva samples were collected at baseline, at 30 days after xylitol usage began, and at 30 days beyond its interruption. MS salivary levels were estimated. The average salivary levels of MS in the ten subjects who completed the study were 13.17 (NL-CFU) at baseline (A). After the 30 days experimental period (B), this average decreased to 9.45 (NL-CFU). Nine of ten subjects studied showed a reduction in MS salivary levels in relation to baseline, whereas salivary levels were maintained in the remaining subject. At thirty days beyond the interruption of xylitol usage (C), the average levels of MS were still reduced to 10.31 (NL-CFU). Multiple sample comparison using the Bonferroni test revealed that the decrease in MS levels observed from baseline (A) to the time immediately after 30 days of xylitol usage (B) was statistically significant (p < 0.05), and those levels were still decreased between baseline and 30 days beyond the interruption of xylitol usage (C). So, the use of xylitol induced a reduction in MS salivary levels after a short period of usage which persisted beyond its interruption.
Documentos Relacionados
- Effect of xylitol-containing chewing gum consumption on salivary mutans streptococci levels, on genotypes of S.mutans and on the presence of xylitol-resistant strains in saliva.
- Chewing gum for extradural haemorrhage
- Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system
- Reduced salivary flow and colonization by mutans streptococci in children with Down syndrome
- Porphyridum Cruentum as a natural colorant in chewing gum